MRNA Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
20.83%
Last Quarter
- $0.51
Past Year
- $8.06
Growth Past 5yrs
-42.94%
Next Quarter
- $2.62
Estimate Next Year
$46.76
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$99.00
192.38% Upside
Mean Price Target
$39.41
16.38% Upside
Lowest Price Target
$15.00
-55.7% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
MRNA Earnings Per Share (EPS) History
According to financial reports, MRNA (NYSE: MRNA) reported an actual EPS of $-0.51282 for the quarter ending on Nov 06, 2025, compared to an estimated $-2.15, resulting in a -76.15% surprise. In the prior quarter (Aug 01, 2025), MRNA recorded an actual EPS of $-2.13 with a -28.76% surprise. See MRNA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
MRNA has experienced notable EPS surprises, with the latest quarter ending Nov 06, 2025 showing a -76.15% miss. Previously, the quarter ending Aug 01, 2025 recorded a -28.76% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Nov 06, 2025 | -0.51282 | -2.15 | -76.15% |
| Aug 01, 2025 | -2.13 | -2.99 | -28.76% |
| May 01, 2025 | -2.52 | -2.92 | -13.70% |
| Feb 14, 2025 | -2.5 | -2.68 | -6.72% |
| Nov 07, 2024 | 0.03258 | -1.9 | -101.71% |
| Aug 01, 2024 | -3.33 | -3.35 | -0.60% |
Frequently Asked Questions
Is MRNA stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given MRNA stock an average recommendation of
Hold. 27 analysts have given their ratings
to MRNA out of which
1 analysts have given strong buy call,
4 analysts have given buy call,
15 analysts rate it hold,
7 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$39.41 gives the stock implied upside
of roughly 16.38% over the next year or so.
What have analysts suggested for MRNA highest price target?
Analysts suggest MRNA's stock price would rise to a high of $99.00.
What is the lowest price target analysts expect for MRNA over the next year?
Within the next 12 months, analysts predict the MRNA stock price could move to $15.00.
What is the average target price for MRNA?
MRNA stock has an average analyst estimate of $39.41.
At its current price, how far is MRNA from its average target price?
MRNA shares are currently trading 16.38% above this price target.
What were MRNA’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.51 versus consensus estimates of - $2.15, and below the comparable year-ago quarter’s EPS of $0.03.
What are the current estimates for quarterly and annual earnings per share?
MRNA's forecasts by analysts estimating quarterly EPS at - $2.62 and $46.76 for the whole year.
What has MRNA's growth been in the past five years and what is expected in the next five years?
The analysts have projected 20.83% EPS growth for MRNA in the next five years, compared to growth rates of -42.94% in the past five years.